The Hong Kong and China Gas Company Limited (HOKCY)

Market Cap	16.50B
Revenue (ttm)	7.14B
Net Income (ttm)	735.31M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	22.44
Forward PE	20.62
Dividend	0.02 (2.66%)
Ex-Dividend Date	Jun 6, 2025

Volume	547
Average Volume	5,030
Open	0.8561
Previous Close	0.8800
Day's Range	0.8561 - 0.8561
52-Week Range	0.6500 - 0.9899
Beta	0.56
RSI	53.03
Earnings Date	Aug 15, 2025

About Revance Therapeutics

The Hong Kong and China Gas Company Limited, together with its subsidiaries, produces, distributes, and markets gas, water supply and energy services in Hong Kong and Mainland China. It is involved in the provision of renewable energy solutions, piped city-gas projects, gas supply chain, water supply, and urban waste utilization projects, as well as new energy exploration and utilisation ventures. The company also offers piping installation services; piping design services for different properties and retrofit projects; kitchen design solutions...

• Industry: Utilities - Regulated Gas
• Sector: Utilities
• Founded: 1862
• Employees: 56,401
• Stock Exchange: OTCMKTS
• Ticker Symbol: HOKCY

Financial Performance

In 2024, HOKCY's revenue was 55.47 billion, a decrease of -2.63% compared to the previous year's 56.97 billion. Earnings were 5.71 billion, a decrease of -5.91%.